NZ532271A - Peptide mimics of conserved gonococcal epitopes and methods and compositions using them - Google Patents
Peptide mimics of conserved gonococcal epitopes and methods and compositions using themInfo
- Publication number
- NZ532271A NZ532271A NZ532271A NZ53227100A NZ532271A NZ 532271 A NZ532271 A NZ 532271A NZ 532271 A NZ532271 A NZ 532271A NZ 53227100 A NZ53227100 A NZ 53227100A NZ 532271 A NZ532271 A NZ 532271A
- Authority
- NZ
- New Zealand
- Prior art keywords
- epitopes
- compositions
- methods
- conserved
- peptide mimics
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003278 mimic effect Effects 0.000 abstract 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A peptide mimic of a conserved gonococaal epitope not found on human blood group antigens is capable of inducing an immune response against the epitope, is less than 50 amino acids in length and binds to the monoclonal antibody 2C7, with the proviso that the peptide doe not comprises the sequence DE_GLF. The mimic can be used in a composition for immunizing against N. gonorrhoeae infection.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16249199P | 1999-10-29 | 1999-10-29 | |
NZ518915A NZ518915A (en) | 1999-10-29 | 2000-10-27 | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them for immunizing against Neisseria gonorrhoeae |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ532271A true NZ532271A (en) | 2006-03-31 |
Family
ID=22585848
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ518915A NZ518915A (en) | 1999-10-29 | 2000-10-27 | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them for immunizing against Neisseria gonorrhoeae |
NZ532271A NZ532271A (en) | 1999-10-29 | 2000-10-27 | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ518915A NZ518915A (en) | 1999-10-29 | 2000-10-27 | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them for immunizing against Neisseria gonorrhoeae |
Country Status (7)
Country | Link |
---|---|
CN (2) | CN101638433B (en) |
AP (1) | AP1638A (en) |
AU (1) | AU785022B2 (en) |
HK (1) | HK1141034A1 (en) |
NZ (2) | NZ518915A (en) |
OA (1) | OA12315A (en) |
WO (1) | WO2001032692A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899096B (en) * | 2010-07-07 | 2012-07-04 | 南方医科大学 | Blood group A epitope mimic peptide and application thereof |
CN101899097B (en) * | 2010-07-07 | 2012-02-01 | 南方医科大学 | Blood group B epitope mimic peptide and application thereof |
WO2021061676A1 (en) | 2019-09-23 | 2021-04-01 | University Of Massachusetts | Multi-antigenic peptide mimics of gonococcal lipo-oligosaccharide (los) epitopes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5476784A (en) * | 1993-04-06 | 1995-12-19 | Rice; Peter A. | Gonococcal anti-idiotypic antibodies and methods and compositions using them |
GB9611673D0 (en) * | 1996-06-05 | 1996-08-07 | Peptide Therapeutics Ltd | Meningococcal vaccine |
US6528061B1 (en) * | 1997-09-04 | 2003-03-04 | Pasteur Institut | Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions |
JP2002502605A (en) * | 1998-02-09 | 2002-01-29 | ジェンセット | CDNA encoding secreted protein |
-
2000
- 2000-10-27 WO PCT/US2000/029749 patent/WO2001032692A2/en active IP Right Grant
- 2000-10-27 CN CN200910136894.6A patent/CN101638433B/en not_active Expired - Fee Related
- 2000-10-27 NZ NZ518915A patent/NZ518915A/en not_active IP Right Cessation
- 2000-10-27 OA OA1200200130A patent/OA12315A/en unknown
- 2000-10-27 AP APAP/P/2002/002511A patent/AP1638A/en active
- 2000-10-27 CN CN008170983A patent/CN1409725B/en not_active Expired - Fee Related
- 2000-10-27 AU AU12420/01A patent/AU785022B2/en not_active Ceased
- 2000-10-27 NZ NZ532271A patent/NZ532271A/en not_active IP Right Cessation
-
2010
- 2010-08-03 HK HK10107364.1A patent/HK1141034A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AP1638A (en) | 2006-07-20 |
AU785022B2 (en) | 2006-08-24 |
NZ518915A (en) | 2004-05-28 |
CN101638433B (en) | 2014-10-29 |
OA12315A (en) | 2006-05-15 |
WO2001032692A2 (en) | 2001-05-10 |
CN101638433A (en) | 2010-02-03 |
AU1242001A (en) | 2001-05-14 |
WO2001032692A3 (en) | 2002-03-07 |
CN1409725A (en) | 2003-04-09 |
AP2002002511A0 (en) | 2002-06-30 |
CN1409725B (en) | 2012-06-06 |
HK1141034A1 (en) | 2010-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE127345T1 (en) | STRESS PROTEINS AND USES THEREOF. | |
DK0561907T3 (en) | Proteins with altered epitopes and methods for their preparation | |
TR199801722T2 (en) | Peptide imm�nojenler. | |
PT1198250E (en) | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens | |
NZ237611A (en) | Variant hepatitis b surface antigen | |
DE69327587D1 (en) | Conjugates of weakly immunogenic antigenic and synthetic peptide carriers and vaccines containing them | |
KR910016343A (en) | Serum Reactive Epitopes of Human Papillomavirus (HPV) 16 Protein | |
GB2255093A (en) | Hiv-1 core protein fragments | |
HU9300877D0 (en) | Method for producing proteines applicables by injection and inducing anti-bodies having neutralizing effect against virus of human immun insufficiency | |
DE69534617D1 (en) | Hepatitis b-impfstoff | |
HUP9801223A2 (en) | Method for enhancing the antibody response to specific antigens with interleukin-10 | |
NZ331557A (en) | Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis | |
WO1999011660A3 (en) | Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions | |
NZ532271A (en) | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them | |
EP0153871A3 (en) | Antibody enhancement of immunogenicity of antigen | |
EP0348725A3 (en) | Species-specific epitode of chlamydia trachomatis and antibodies that recognize the same | |
EP0320866A3 (en) | A protective immunodominant epitope included in the s1 subunit of pertussis toxin | |
NZ515332A (en) | Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses | |
Orban et al. | A factor shed by lymphoblastoid cell lines of HLA-B27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals. | |
ES8800052A1 (en) | Anaplasma marginale subunit antigen for vaccination and diagnosis. | |
GR3021983T3 (en) | Cross-reactive influenza a immunization | |
ATE175357T1 (en) | CONTRACTIVE VACCINE | |
GB2314560A (en) | Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use | |
RU93004854A (en) | PEPTIDES FOR VACCINATION AND INDUCTION OF NEUTRALIZING ANTIBODIES AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY | |
BG51731A1 (en) | Hybridome cellular line mus musculus balb/c, secreting monoclonal antibody against antigenic deternimant, common for the strains hantaan and finnish of the virus of haemorrhagic fever with nephritic syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AVOD | Application void | ||
CORR | Corrigendum |
Free format text: ADVERTISED IN JOURNAL 1520 AS VOID IN ERROR AND HAS BEEN ACCEPTED IN THE MAIN BODY OF THIS JOURNAL |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 27 OCT 2020 BY COMPUTER PACKAGES INC Effective date: 20131026 |
|
EXPY | Patent expired |